{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:19:59Z","timestamp":1781111999680,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.abd.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T11:39:32Z","timestamp":1715427572000},"page":"815-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of clinical characteristics and factors affecting treatment responses in patients with pyoderma gangrenosum: a multicenter study of 239 patients\u2606"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3318-2248","authenticated-orcid":false,"given":"Funda","family":"Erduran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8768-231X","authenticated-orcid":false,"given":"Esra","family":"Ad\u0131\u015fen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1942-7285","authenticated-orcid":false,"given":"Y\u0131ld\u0131z","family":"Hayran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4118-4243","authenticated-orcid":false,"given":"G\u00fcne\u015f G\u00fcr","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-0170","authenticated-orcid":false,"given":"Erkan","family":"Alpsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7956-4033","authenticated-orcid":false,"given":"Leyla Baykal","family":"Sel\u00e7uk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-6886","authenticated-orcid":false,"given":"Sibel Do\u011fan","family":"G\u00fcnayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6364-5047","authenticated-orcid":false,"given":"Ay\u00e7a Cordan","family":"Yaz\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3810-6188","authenticated-orcid":false,"given":"Ay\u015fe","family":"\u00d6ktem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3563-4527","authenticated-orcid":false,"given":"Malik","family":"G\u00fcng\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7912-2745","authenticated-orcid":false,"given":"Elif","family":"Afacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4758-2146","authenticated-orcid":false,"given":"Deniz Devrim","family":"Ku\u015f\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-1264","authenticated-orcid":false,"given":"Leyla","family":"Elmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2374-688X","authenticated-orcid":false,"given":"K\u00fcbra","family":"Aydo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-0019","authenticated-orcid":false,"given":"Dilek","family":"Bayramg\u00fcrler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8120-9548","authenticated-orcid":false,"given":"Evren Odyakmaz","family":"Demirsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7912-0651","authenticated-orcid":false,"given":"Melih","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5154-4652","authenticated-orcid":false,"given":"Rukiye Yasak","family":"G\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8172-1920","authenticated-orcid":false,"given":"Hilal Kaya","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6041-6636","authenticated-orcid":false,"given":"Ersoy","family":"Acer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-6298","authenticated-orcid":false,"given":"Tulin","family":"Ergun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9402-940X","authenticated-orcid":false,"given":"Sava\u015f","family":"Yayl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3931-6785","authenticated-orcid":false,"given":"Ferhan","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-9733","authenticated-orcid":false,"given":"Esra","family":"Sara\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4972-6713","authenticated-orcid":false,"given":"Ak\u0131n","family":"Akta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2024.02.002_bib0005","first-page":"1","article-title":"Nouvelle contribution a I\u2019etude du phagedenisme geometrique","volume":"6","author":"Brocq","year":"1916","journal-title":"Ann Dermatol Syphil."},{"key":"10.1016\/j.abd.2024.02.002_bib0010","first-page":"655","article-title":"Pyoderma (echtyma) gangrenosum","volume":"22","author":"Brunsting","year":"1930","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2024.02.002_bib0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000247696","article-title":"Cutaneous manifestations of neutrophilic disease. A study of seven cases","volume":"183","author":"Vignon-Pennamen","year":"1991","journal-title":"Dermatologica."},{"key":"10.1016\/j.abd.2024.02.002_bib0020","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco","year":"2009","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2024.02.002_bib0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/iwj.12939","article-title":"Epidemiology of pyoderma gangrenosum: results from an Italian prospective multicentre study","volume":"15","author":"Monari","year":"2018","journal-title":"Int Wound J."},{"key":"10.1016\/j.abd.2024.02.002_bib0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1534734616639172","article-title":"Pyoderma gangrenosum: a report of 27 patients","volume":"15","author":"Ad\u0131\u015fen","year":"2016","journal-title":"Int J Low Extrem Wounds."},{"key":"10.1016\/j.abd.2024.02.002_bib0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma Gangrenosum: an update on pathophysiology, diagnosis and treatment","volume":"18","author":"Alavi","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2024.02.002_bib0040","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1111\/1346-8138.16845","article-title":"Clinical guidance of pyoderma gangrenosum 2022","volume":"50","author":"Yamamoto","year":"2023","journal-title":"J Dermatol."},{"key":"10.1016\/j.abd.2024.02.002_bib0045","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","article-title":"Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria","volume":"43","author":"Su","year":"2004","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2024.02.002_bib0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a delphi consensus of international experts","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2024.02.002_bib0055","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0003-066X.55.5.469","article-title":"Emerging adulthood. A theory of development from the late teens through the twenties","volume":"55","author":"Arnett","year":"2000","journal-title":"Am Psychol."},{"key":"10.1016\/j.abd.2024.02.002_bib0060","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1037\/amp0000600","article-title":"Established adulthood: a new conception of ages 30 to 45","volume":"75","author":"Mehta","year":"2020","journal-title":"Am Psychol."},{"key":"10.1016\/j.abd.2024.02.002_bib0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamadermatol.2017.5978","article-title":"The association of age with clinical presentation and comorbidities of Pyoderma Gangrenosum","volume":"154","author":"Ashchyan","year":"2018","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2024.02.002_bib0070","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/jid.2012.130","article-title":"Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.abd.2024.02.002_bib0075","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3776","article-title":"a retrospective study of clinical characteristics, comorbidities, response to treatment and mortality related to prednisone dose","volume":"101","author":"Sch\u00f8sler","year":"2021","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.abd.2024.02.002_bib0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1750-1172-8-136","article-title":"Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients","volume":"8","author":"Al Ghazal","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.abd.2024.02.002_bib0085","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2024.02.002_bib0090","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/bjd.14619","article-title":"Treatment of pyoderma gangrenosum: retrospective multicentre analysis of 121 patients","volume":"175","author":"Herberger","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2024.02.002_bib0095","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/bjd.15561","article-title":"Ciclosporin compared with prednisolone therapy for patients with pyoderma gangrenosum: cost-effectiveness analysis of the STOP GAP trial","volume":"177","author":"Mason","year":"2017","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2024.02.002_bib0100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma Gangrenosum: an updated literature review on established and emerging pharmacological treatments","volume":"23","author":"Maronese","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2024.02.002_bib0105","first-page":"1058","article-title":"Efficacy of systemic dapsone treatment for Pyoderma Gangrenosum: a retrospective review","volume":"17","author":"Din","year":"2018","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.abd.2024.02.002_bib0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000079897","article-title":"Treatment of Pyoderma gangrenosum with low-dose colchicine","volume":"209","author":"Kontochristopoulos","year":"2004","journal-title":"Dermatology."},{"key":"10.1016\/j.abd.2024.02.002_bib0115","first-page":"326","article-title":"Treatment of PG with methotrexate","volume":"57","author":"Teitel","year":"1996","journal-title":"Cutis."},{"key":"10.1016\/j.abd.2024.02.002_bib0120","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/09546634.2019.1606888","article-title":"Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum","volume":"31","author":"Haag","year":"2020","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.abd.2024.02.002_bib0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut."},{"key":"10.1016\/j.abd.2024.02.002_bib0130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1358\/dot.2021.57.9.3293619","article-title":"An update on adalimumab for pyoderma gangrenosum","volume":"57","author":"Yamamoto","year":"2021","journal-title":"Drugs Today (Barc)."},{"key":"10.1016\/j.abd.2024.02.002_bib0135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/iwj.13067","article-title":"Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: a semi-systematic review","volume":"16","author":"Ben Abdallah","year":"2019","journal-title":"Int Wound J."},{"key":"10.1016\/j.abd.2024.02.002_bib0140","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1159\/000519320","article-title":"Pyoderma Gangrenosum and interleukin inhibitors: a semi-systematic review","volume":"238","author":"Ben Abdallah","year":"2022","journal-title":"Dermatology."},{"key":"10.1016\/j.abd.2024.02.002_bib0145","article-title":"Pyoderma gangrenosum treated with secukinumab: a case report","volume":"8","author":"McPhie","year":"2020","journal-title":"SAGE Open Med Case Rep."},{"key":"10.1016\/j.abd.2024.02.002_bib0150","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/iwj.13359","article-title":"Successful treatment of a refractory pyoderma gangrenosum with risankizumab","volume":"17","author":"Burgdorf","year":"2020","journal-title":"Int Wound J."},{"key":"10.1016\/j.abd.2024.02.002_bib0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdcr.2023.05.002","article-title":"Targeted therapy with ixekizumab in pyoderma gangrenosum: a case series and a literature overview","volume":"37","author":"Kao","year":"2023","journal-title":"JAAD Case Rep."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:51Z","timestamp":1747666851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059624000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0365059624000795"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2024.02.002","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of clinical characteristics and factors affecting treatment responses in patients with pyoderma gangrenosum: a multicenter study of 239 patients\u2606","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}